Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (28042) 28042
Publication (4577) 4577
Newsletter (3874) 3874
Newspaper Article (376) 376
Book / eBook (221) 221
Book Review (210) 210
Magazine Article (128) 128
Book Chapter (61) 61
Conference Proceeding (43) 43
Transcript (28) 28
Web Resource (25) 25
Trade Publication Article (19) 19
Data Set (12) 12
Reference (9) 9
Dissertation (4) 4
Journal / eJournal (3) 3
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (19371) 19371
mycoses (13239) 13239
index medicus (11062) 11062
male (9156) 9156
bacterial infections and mycoses (9130) 9130
female (8527) 8527
adult (6309) 6309
middle aged (6004) 6004
mycoses - drug therapy (5789) 5789
microbiology (5760) 5760
antifungal agents - therapeutic use (5133) 5133
infectious diseases (4787) 4787
health aspects (4715) 4715
antifungal agents (4576) 4576
research (4491) 4491
aged (4138) 4138
animals (3650) 3650
infection (3441) 3441
infections (3197) 3197
care and treatment (3146) 3146
biochemical phenomena, metabolism, and nutrition (3108) 3108
diagnosis (2914) 2914
adolescent (2846) 2846
mycoses - microbiology (2830) 2830
pharmacology & pharmacy (2768) 2768
risk factors (2735) 2735
microbial sensitivity tests (2599) 2599
immunology (2554) 2554
research article (2420) 2420
drug therapy (2406) 2406
child (2359) 2359
bacteria (2322) 2322
mycoses - diagnosis (2279) 2279
analysis (2274) 2274
epidemiology (2252) 2252
medical research (2243) 2243
treatment outcome (2173) 2173
medicine (2118) 2118
medicine, experimental (2065) 2065
fungi (1955) 1955
retrospective studies (1937) 1937
anti-bacterial agents - therapeutic use (1842) 1842
mortality (1816) 1816
dermatology (1787) 1787
antifungal agents - pharmacology (1699) 1699
transplantation (1668) 1668
mycology (1641) 1641
therapy (1603) 1603
polycyclic compounds (1594) 1594
young adult (1561) 1561
mycoses - etiology (1544) 1544
fungal infections (1525) 1525
cancer (1496) 1496
antifungal agents - administration & dosage (1493) 1493
amphotericin b - therapeutic use (1488) 1488
antibiotics (1469) 1469
child, preschool (1468) 1468
fluconazole (1452) 1452
aged, 80 and over (1370) 1370
mycoses - complications (1351) 1351
anti-bacterial agents - pharmacology (1339) 1339
aspergillosis (1323) 1323
mycoses - prevention & control (1318) 1318
mycoses - therapy (1313) 1313
mice (1274) 1274
mycoses - epidemiology (1244) 1244
voriconazole (1242) 1242
drug resistance (1223) 1223
immunocompromised host (1210) 1210
infectious and parasitic diseases (1209) 1209
patients (1170) 1170
amphotericin-b (1121) 1121
infant (1119) 1119
prevalence (1108) 1108
onychomycosis (1107) 1107
tuberculosis (1092) 1092
disease (1088) 1088
itraconazole (1086) 1086
surgery (1059) 1059
drug therapy, combination (1048) 1048
hospitals (1024) 1024
article (1022) 1022
medicine, general & internal (1021) 1021
amphotericin b (983) 983
pediatrics (982) 982
internal medicine (978) 978
children (970) 970
hematology (968) 968
medicine & public health (962) 962
risk-factors (928) 928
drugs (907) 907
prospective studies (897) 897
skin (894) 894
susceptibility (894) 894
drug resistance in microorganisms (882) 882
universities and colleges (874) 874
multidisciplinary sciences (865) 865
candidiasis (863) 863
usage (863) 863
antifungal agents - adverse effects (862) 862
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (132) 132
Online Resources - Online (21) 21
Collection Dvlpm't (Acquisitions) - Vendor file (11) 11
Collection Dvlpm't (Acquisitions) - Closed Orders (9) 9
Earth Sciences (Noranda) - Stacks (7) 7
Royal Ontario Museum - Stacks (5) 5
UofT at Mississauga - Stacks (5) 5
Scarborough Hospital - Online (3) 3
UTL at Downsview - May be requested (3) 3
Gerstein Science - Circulation Desk (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Credit Valley Hospital - Stacks (1) 1
Gerstein Science - Bindery (1) 1
Gerstein Science - Periodical Stacks (1) 1
Law (Bora Laskin) - Stacks (1) 1
Scarborough Hospital - General (1) 1
St. Michael's Hospital - Stacks (1) 1
Toronto East General Hospital - Stacks (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (30455) 30455
German (554) 554
French (418) 418
Spanish (290) 290
Japanese (235) 235
Russian (178) 178
Chinese (114) 114
Turkish (113) 113
Italian (98) 98
Polish (95) 95
Czech (36) 36
Portuguese (32) 32
Dutch (29) 29
Hungarian (28) 28
Romanian (18) 18
Swedish (11) 11
Finnish (10) 10
Norwegian (10) 10
Danish (9) 9
Hebrew (8) 8
Serbian (8) 8
Arabic (7) 7
Slovak (6) 6
Croatian (5) 5
Ukrainian (4) 4
Bulgarian (3) 3
Lithuanian (2) 2
Afrikaans (1) 1
Greek (1) 1
Korean (1) 1
Slovenian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Update on musculoskeletal infections
by Ross, John J and Moellering, Robert C
2005, Infectious disease clinics of North America, ISBN 9781416026709, Volume 19, no. 4., xiv p. 765-1043
Osteomyelitis | Musculoskeletal system | Infections | Orthopedic surgery | Complications
Book
Details down arrow
2. Dorothy Stopford Price
: rebel doctor
by Mac Lellan, Anne
2014, ISBN 9780716532361, xi, 268 p., 8 p. of plates
Stopford Price, Dorothy, 1890-1954 | Women physicians | Nationalists | Mass Vaccination | Ireland | Physicians, Women | history | Tuberculosis, Pulmonary
Book
Details down arrow
3. Full Text Intravenous and oral itraconazole versus intravenous amphotericin B deoxycholate as empirical antifungal therapy for persistent fever in neutropenic patients with cancer who are receiving broad-spectrum antibacterial therapy - A randomized, controlled trial
by Boogaerts, M and Winston, DJ and Bow, EJ and Garber, G and Reboli, AC and Schwarer, AP and Novitzky, N and Boehme, A and Chwetzoff, E and De Beule, K and Itraconazole Neutropenia Study Grp and Itraconazole Neutropenia Study Group
Annals of Internal Medicine, ISSN 0003-4819, 09/2001, Volume 135, Issue 6, pp. 412 - 422
Background: Amphotericin B deoxycholate is currently the standard empirical antifungal therapy in neutropenic patients with cancer who have persistent fever... 
MEDICINE, GENERAL & INTERNAL | UNEXPLAINED FEVER | BLOOD-STREAM INFECTION | CANDIDA-ALBICANS | CLINICAL-TRIAL | NATIONAL SURVEILLANCE | ACUTE MYELOGENOUS LEUKEMIA | SUSCEPTIBILITY | SCOPE PROGRAM | FLUCONAZOLE | FUNGAL-INFECTIONS | Antifungal Agents - adverse effects | Administration, Oral | Humans | Risk Factors | Neoplasms - drug therapy | Amphotericin B - adverse effects | Anti-Bacterial Agents - therapeutic use | Neoplasms - complications | Deoxycholic Acid - adverse effects | Antineoplastic Agents - adverse effects | Itraconazole - adverse effects | Opportunistic Infections - drug therapy | Treatment Failure | Fever - etiology | Mycoses - drug therapy | Amphotericin B - administration & dosage | Itraconazole - administration & dosage | Deoxycholic Acid - administration & dosage | Mycoses - complications | Infusions, Intravenous | Antifungal Agents - administration & dosage | Drug Combinations | Neutropenia - immunology | Opportunistic Infections - complications | Prevention | Mycoses | Evaluation | Amphotericin B | Itraconazole
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Therapy of fungus diseases
: and international symposium
by Sternberg, Thomas Hunter and University of California, Los Angeles. School of Medicine and Medical Extension
1955, 1st ed., 337
Mycosis
Book
Details down arrow
5. Vaccines
: preventing disease & protecting health
by Quadros, Ciro A. de and Pan American Health Organization
2004, Scientific and technical publication (Washington, D.C.), ISBN 9275115966, Volume no. 596, xiii, 398
Prevention | Immunization | Vaccination | Communicable diseases | Immunization Programs | World Health | Vaccines | immunology
Book
Details down arrow
6. Antibacterial therapy
: achievements, problems, and future perspectives
by Busse, W.-D and Zeiler, H. J and Labischinski, H and Metzger, Karl-Georg
1997, ISBN 3540628967, xiv, 77
Bacterial diseases | Antibacterial agents | Chemotherapy
Book
Details down arrow
7. Full Text Epidemiology and Outcome of Invasive Fungal Infection in Adult Hematopoietic Stem Cell Transplant Recipients: Analysis of Multicenter Prospective Antifungal Therapy (PATH) Alliance Registry
by D. Neofytos and D. Horn and E. Anaissie and W. Steinbach and A. Olyaei and J. Fishman and M. Pfaller and C. Chang and K. Webster and K. Marr
Clinical Infectious Diseases, ISSN 1058-4838, 2/2009, Volume 48, Issue 3, pp. 265 - 273
Background. With use of data from the Prospective Antifungal Therapy (PATH) Alliance registry, we performed this multicenter, prospective, observational study... 
Antifungals | Aspergillus | Health outcomes | Mortality | Articles and Commentaries | Predisposing factors | Transplantation | Infections | Fungal infections | Epidemiology | Hematopoietic stem cells | ASPERGILLOSIS | INFECTIOUS DISEASES | PROGNOSTIC-FACTORS | FLUCONAZOLE PROPHYLAXIS | MICROBIOLOGY | DEATH | MARROW-TRANSPLANTATION | IMMUNOLOGY | CANCER | Mycoses - epidemiology | Mucorales - isolation & purification | Prevalence | Prospective Studies | Humans | Middle Aged | Fungi - isolation & purification | Male | North America | Antifungal Agents - therapeutic use | Hematopoietic Stem Cell Transplantation - adverse effects | Voriconazole | Aspergillus - isolation & purification | Adult | Female | Triazoles - therapeutic use | Risk Factors | Deoxycholic Acid - therapeutic use | Logistic Models | Treatment Outcome | Candida - isolation & purification | Pyrimidines - therapeutic use | Mycoses - drug therapy | Aged | Mycoses - mortality | Amphotericin B - therapeutic use | Drug Combinations | Complications and side effects | Demographic aspects | Patient outcomes | Distribution | Mycoses | Organ transplant recipients | Research | Health aspects
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease
by Rahier, J.F and Magro, F and Abreu, C and Armuzzi, A and Ben-Horin, S and Chowers, Y and Cottone, M and de Ridder, L and Doherty, G and Ehehalt, R and Esteve, M and Katsanos, K and Lees, C.W and MacMahon, E and Moreels, T and Reinisch, W and Tilg, H and Tremblay, L and Veereman-Wauters, G and Viget, N and Yazdanpanah, Y and Eliakim, R and Colombel, J.F and ECCO and European Crohn's and Colitis Organisation (ECCO)
Journal of Crohn's and Colitis, ISSN 1873-9946, 06/2014, Volume 8, Issue 6, pp. 443 - 468
Inflammatory bowel disease | ECCO guidelines | Opportunistic infections | GASTROENTEROLOGY & HEPATOLOGY | HIV Infections - prevention & control | Hepatitis C - therapy | Age Factors | Herpesviridae Infections - etiology | Humans | Middle Aged | Opportunistic Infections - prevention & control | Opportunistic Infections - therapy | Papillomavirus Infections - diagnosis | Herpesviridae Infections - prevention & control | Papillomavirus Infections - therapy | Parasitic Diseases - etiology | Opportunistic Infections - etiology | Young Adult | Parasitic Diseases - therapy | HIV Infections - diagnosis | Mycoses - therapy | Adult | Influenza, Human - diagnosis | Papillomavirus Infections - etiology | Hepatitis C - prevention & control | Inflammatory Bowel Diseases - complications | Influenza, Human - therapy | Mycoses - prevention & control | Hepatitis B - therapy | Risk Factors | Parasitic Diseases - prevention & control | Herpesviridae Infections - diagnosis | Influenza, Human - etiology | Opportunistic Infections - diagnosis | Hepatitis B - diagnosis | Hepatitis B - etiology | Hepatitis C - diagnosis | HIV Infections - etiology | Herpesviridae Infections - therapy | Papillomavirus Infections - prevention & control | Adolescent | HIV Infections - therapy | Mycoses - diagnosis | Parasitic Diseases - diagnosis | Hepatitis B - prevention & control | Immunocompromised Host | Hepatitis C - etiology | Influenza, Human - prevention & control | Mycoses - etiology
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Empirical versus Preemptive Antifungal Therapy for High-Risk, Febrile, Neutropenic Patients: A Randomized, Controlled Trial
by Catherine Cordonnier and Cécile Pautas and Sébastien Maury and Anne Vekhoff and Hassan Farhat and Felipe Suarez and Nathalie Dhédin and Francoise Isnard and Lionel Ades and Frédérique Kuhnowski and Françoise Foulet and Mathieu Kuentz and Patrick Maison and Stéphane Bretagne and Michaël Schwarzinger
Clinical Infectious Diseases, ISSN 1058-4838, 4/2009, Volume 48, Issue 8, pp. 1042 - 1051
Background. Empirical antifungal therapy is the standard of care for neutropenic patients with hematological malignancies who remain febrile despite... 
Antifungals | Antibacterials | Induction chemotherapy | Sample size | Articles and Commentaries | Aspergillosis | Fungal infections | Consolidation chemotherapy | Fever | Neutropenia | Teaching hospitals | INFECTIOUS DISEASES | GALACTOMANNAN | MULTICENTER | MICROBIOLOGY | INVASIVE FUNGAL-INFECTIONS | ITRACONAZOLE | IMMUNOLOGY | PERSISTENT FEVER | LIPOSOMAL AMPHOTERICIN-B | ASPERGILLOSIS | CANCER-PATIENTS | CLINICAL-TRIALS | FLUCONAZOLE | Humans | Middle Aged | Male | Antibiotic Prophylaxis | Opportunistic Infections - prevention & control | Fever - physiopathology | Antifungal Agents - therapeutic use | Neutropenia - complications | Multicenter Studies as Topic | Statistics, Nonparametric | Amphotericin B - administration & dosage | Adult | Female | Deoxycholic Acid - administration & dosage | Mycoses - prevention & control | Risk Factors | Deoxycholic Acid - therapeutic use | Chi-Square Distribution | Opportunistic Infections - drug therapy | Mycoses - drug therapy | Mycoses - diagnosis | Aged | Mycoses - complications | Amphotericin B - therapeutic use | Antifungal Agents - administration & dosage | Drug Combinations | Care and treatment | Patient outcomes | Antifungal agents | Dosage and administration | Research | Drug therapy | Hyperthermia | Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
10. Full Text Antifungal photodynamic therapy
by Donnelly, Ryan F and McCarron, Paul A and Tunney, Michael M
Microbiological Research, ISSN 0944-5013, 2008, Volume 163, Issue 1, pp. 1 - 12
In photodynamic antimicrobial chemotherapy (PACT), a combination of a sensitising drug and visible light causes selective destruction of microbial cells. The... 
Yeasts | Photosensitisers | Photodynamic antimicrobial chemotherapy | Dermatomycetes | FLUCYTOSINE RESISTANCE | KERATINOCYTES IN-VITRO | MICROBIOLOGY | yeasts | SACCHAROMYCES-CEREVISIAE | photosensitisers | DERMATOPHYTE TRICHOPHYTON-RUBRUM | YEAST-CELLS | CHLOROALUMINUM-PHTHALOCYANINE | photodynamic antimicrobial chemotherapy | CANDIDA-ALBICANS | 5-AMINOLEVULINIC ACID | dermatomycetes | CATIONIC PORPHYRIN | POWER LASER-LIGHT | Aminolevulinic Acid - chemistry | Photosensitizing Agents - chemistry | Porphyrins - therapeutic use | Humans | Porphyrins - chemistry | Aminolevulinic Acid - therapeutic use | Photochemotherapy | Fungi | Photosensitizing Agents - administration & dosage | Radiation-Sensitizing Agents - therapeutic use | Animals | Mycoses - drug therapy | Indoles - therapeutic use | Antifungal Agents | Radiation-Sensitizing Agents - chemistry | Indoles - chemistry | Chemotherapy | Phthalocyanins | Antifungal agents | Mycoses | Health aspects | Porphyrins | Dyes and dyeing | Cancer
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
11. Can intravenous antifungal therapy be safely used in the outpatient parenteral antimicrobial therapy (OPAT) setting?
by Rae, Nikolas and Kenny, Claire and Muldoon, Eavan G
Mycoses, ISSN 0933-7407, 2019, Volume 62, Issue 3, pp. 196 - 203
Outpatient parenteral antimicrobial therapy (OPAT) is an established treatment option for patients with a variety of infections who require a period of... 
antifungal | patient safety | parenteral antifungal therapy | invasive candidosis | outpatient parenteral antimicrobial therapy | DIAGNOSIS | PRACTICE GUIDELINES | RISK-FACTORS | MANAGEMENT | CHRONIC PULMONARY ASPERGILLOSIS | 2016 UPDATE | LIPOSOMAL AMPHOTERICIN-B | DERMATOLOGY | CLINICAL-EFFICACY | MYCOLOGY | INFECTIOUS-DISEASES SOCIETY | FLUCONAZOLE | Intolerance | Intravenous administration | Fungal infections | Patients | Antifungal agents
Journal Article
Details down arrow
12. Full Text Therapy for fungal diseases: opportunities and priorities
by Denning, David W and Hope, William W
Trends in Microbiology, ISSN 0966-842X, 2010, Volume 18, Issue 5, pp. 195 - 204
This article provides a perspective on the current status of drug therapy for invasive fungal diseases, together with priorities for the future development of... 
Internal Medicine | CLINICAL-PRACTICE GUIDELINES | HIGH-DOSE FLUCONAZOLE | INVASIVE ASPERGILLOSIS | PULMONARY ASPERGILLOSIS | DOUBLE-BLIND TRIAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | CARE CANCER CENTER | ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS | MICROBIOLOGY | RANDOMIZED CONTROLLED-TRIAL | CRYPTOCOCCAL MENINGITIS | LIPOSOMAL AMPHOTERICIN-B | Antifungal Agents - pharmacology | Drug Discovery - trends | Mycoses - drug therapy | Mycoses - diagnosis | Mycoses - microbiology | Biomedical Research - trends | Antifungal Agents - chemistry | Drug Resistance, Fungal | Antifungal Agents - therapeutic use
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
13. Full Text Combination Antifungal Therapy
by Johnson, Melissa D and MacDougall, Conan and Ostrosky-Zeichner, Luis and Perfect, John R and Rex, John H
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2004, Volume 48, Issue 3, pp. 693 - 715
ACQUIRED-IMMUNODEFICIENCY-SYNDROME | IN-VITRO INTERACTION | MURINE CRYPTOCOCCAL MENINGITIS | POLYMERASE-CHAIN-REACTION | ALLOGENEIC MARROW TRANSPLANTATION | ACUTE LYMPHOBLASTIC-LEUKEMIA | ITRACONAZOLE ORAL SOLUTION | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | AMPHOTERICIN-B ANTAGONISM | INVASIVE FUNGAL-INFECTIONS | SEQUENCE-BASED AMPLIFICATION | Antifungal Agents - pharmacology | Animals | Drug Interactions | Fungi - drug effects | Humans | Mycoses - drug therapy | Drug Combinations | Antifungal Agents - therapeutic use | Minireview
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
14. Full Text Efficacy and Safety of Canagliflozin, an Inhibitor of Sodium-Glucose Cotransporter 2, When Used in Conjunction With Insulin Therapy in Patients With Type 2 Diabetes
by Neal, Bruce and Perkovic, Vlado and de Zeeuw, Dick and Mahaffey, Kenneth W and Fulcher, Greg and Ways, Kirk and Desai, Mehul and Shaw, Wayne and Capuano, George and Alba, Maria and Jiang, Joel and Vercruysse, Frank and Meininger, Gary and Matthews, David and CANVAS Trial Collaborative Grp and CANVAS Trial Collaborative Group
Diabetes Care, ISSN 0149-5992, 03/2015, Volume 38, Issue 3, pp. 403 - 411
OBJECTIVE There are limited data about the effects of sodium-glucose cotransporter 2 inhibitors when used with insulin. We report the efficacy and safety of... 
METFORMIN | GLYCEMIC CONTROL | PLACEBO | MONOTHERAPY | SULFONYLUREA | SITAGLIPTIN | ENDOCRINOLOGY & METABOLISM | DOUBLE-BLIND | RANDOMIZED-TRIAL | POOLED ANALYSIS | MELLITUS | Glycosuria - chemically induced | Hypovolemia - chemically induced | Thiophenes - adverse effects | Humans | Middle Aged | Glycated Hemoglobin A - drug effects | Male | Thiophenes - administration & dosage | Weight Loss - drug effects | Dose-Response Relationship, Drug | Glomerular Filtration Rate - drug effects | Hypoglycemic Agents - administration & dosage | Urinary Tract Infections - chemically induced | Female | Blood Pressure - drug effects | Drug Therapy, Combination | Glucosides - adverse effects | Double-Blind Method | Insulin - administration & dosage | Treatment Outcome | Hypoglycemia - drug therapy | Sodium-Glucose Transporter 2 - antagonists & inhibitors | Blood Glucose - drug effects | Diabetes Mellitus, Type 2 - blood | Diabetes Mellitus, Type 2 - physiopathology | Canagliflozin | Glucosides - administration & dosage | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Insulin - adverse effects | Mycoses - chemically induced
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
15. Full Text Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: Data from the Prospective Antifungal Therapy (PATH) registry 2004-2008
by Pfaller, Michael A and Andes, David R and Diekema, Daniel J and Horn, David L and Reboli, Annette C and Rotstein, Coleman and Franks, Billy and Azie, Nkechi E
PLoS ONE, ISSN 1932-6203, 07/2014, Volume 9, Issue 7, p. e101510
This analysis describes the epidemiology and outcomes of invasive candidiasis caused by non-albicans species of Candida in patients enrolled in the Prospective... 
MULTIDISCIPLINARY SCIENCES | STANDARDIZED DISK DIFFUSION | SURVEILLANCE-PROGRAM | AMPHOTERICIN-B | IN-VITRO SUSCEPTIBILITIES | OF-THE-LITERATURE | TEMPORAL TRENDS | OPPORTUNISTIC FUNGAL PATHOGEN | BLOOD-STREAM INFECTIONS | ESCMID-ASTERISK GUIDELINE | ECHINOCANDIN RESISTANCE | Fluconazole - pharmacology | Prevalence | Prospective Studies | Humans | Middle Aged | Child, Preschool | Infant | Male | Fluconazole - therapeutic use | Antifungal Agents - therapeutic use | Candidiasis, Invasive - mortality | Young Adult | Candidiasis, Invasive - drug therapy | Aged, 80 and over | Adult | Female | Registries | Drug Therapy, Combination | Child | Echinocandins - pharmacology | Antifungal Agents - pharmacology | Candidiasis, Invasive - epidemiology | Survival Rate | Treatment Outcome | Candida - isolation & purification | Adolescent | Echinocandins - therapeutic use | Aged | Candida - drug effects | Infection | Care and treatment | Candidiasis | Fluconazole | Patient outcomes | Analysis | Epidemiology | Therapy | Fungicides | Surgery | Echinocandins | Solid tumors | Patients | Species | Tumors
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
16. Full Text Galactomannan and Computed Tomography-Based Preemptive Antifungal Therapy in Neutropenic Patients at High Risk for Invasive Fungal Infection: A Prospective Feasibility Study
by Johan Maertens and Koen Theunissen and Gregor Verhoef and Johnny Verschakelen and Katrien Lagrou and Eric Verbeken and Alexander Wilmer and Jan Verhaegen and Marc Boogaerts and Johan Van Eldere
Clinical Infectious Diseases, ISSN 1058-4838, 11/2005, Volume 41, Issue 9, pp. 1242 - 1250
Background. Empirical antifungal therapy is the standard treatment for persistent or relapsing antibiotic-resistant neutropenic fever. However, overtreatment... 
Antifungals | Autopsies | Antibiotics | Major Articles | Fungal diseases | Aspergillosis | Computerized axial tomography | Infections | Fungal infections | Disease remission | Fever | VORICONAZOLE | INFECTIOUS DISEASES | EARLY-DIAGNOSIS | ENZYME-IMMUNOASSAY | LINKED-IMMUNOSORBENT-ASSAY | CIRCULATING GALACTOMANNAN | MICROBIOLOGY | IMMUNOLOGY | PERSISTENT FEVER | LIPOSOMAL AMPHOTERICIN-B | CELL TRANSPLANT RECIPIENTS | CANCER-PATIENTS | PULMONARY ASPERGILLOSIS | Lung Diseases, Fungal - prevention & control | Lung Diseases, Fungal - diagnosis | Prospective Studies | Humans | Middle Aged | Aspergillosis - diagnosis | Male | Tomography, X-Ray Computed | Antifungal Agents - therapeutic use | Feasibility Studies | Neutropenia - complications | Adult | Female | Lung Diseases, Fungal - blood | Mycoses - blood | Aspergillosis - blood | Aspergillosis - complications | Mycoses - prevention & control | Risk Factors | Lung Diseases, Fungal - complications | Algorithms | Aspergillosis - prevention & control | Mannans - blood | Adolescent | Mycoses - diagnosis | Aged | Mycoses - complications | Amphotericin B - therapeutic use | Care and treatment | Dosage and administration | Diagnosis | Drug therapy | Antifungal agents | Neutropenia
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
17. Full Text Immunoglobulins in Defense, Pathogenesis, and Therapy of Fungal Diseases
by Casadevall, Arturo and Pirofski, Liise-anne
Cell Host & Microbe, ISSN 1931-3128, 05/2012, Volume 11, Issue 5, pp. 447 - 456
Only two decades ago antibodies to fungi were thought to have little or no role in protection against fungal diseases. However, subsequent research has... 
PARACOCCIDIOIDES-BRASILIENSIS INFECTION | HYPER-IGM SYNDROME | CANDIDA-ALBICANS INFECTION | CAPSULAR POLYSACCHARIDE GLUCURONOXYLOMANNAN | MICROBIOLOGY | MONOCLONAL-ANTIBODY | PASSIVE-IMMUNIZATION | ANTIBODY-MEDIATED PROTECTION | HISTOPLASMA-CAPSULATUM | B-CELLS | VIROLOGY | CRYPTOCOCCUS-NEOFORMANS INFECTION | PARASITOLOGY | Fungi - immunology | Mycoses - prevention & control | Immunotherapy - methods | Immunoglobulins - immunology | Humans | Fungi - pathogenicity | Mycoses - microbiology | Mycoses - therapy | Fungal Vaccines - immunology | Antibodies, Fungal - immunology | Mycoses - immunology | Viral antibodies | Antibodies | Mycoses | Immunoglobulins | Fungal antigens
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights